Clorox (NYSE:CLX) Price Target Raised to $171.00

Clorox (NYSE:CLX) had its price objective lifted by JPMorgan Chase & Co. from $167.00 to $171.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

Other equities analysts have also issued research reports about the company. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. DA Davidson lifted their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $156.54.

Clorox Trading Down 0.1 %

Shares of NYSE:CLX opened at $160.31 on Thursday. The stock has a 50 day moving average of $164.25 and a 200 day moving average of $156.38. The company has a market cap of $19.84 billion, a PE ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42. Clorox has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the business posted $0.49 earnings per share. The company’s revenue was up 27.0% on a year-over-year basis. As a group, equities research analysts expect that Clorox will post 6.87 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.04%. Clorox’s payout ratio is currently 170.04%.

Institutional Investors Weigh In On Clorox

Institutional investors have recently modified their holdings of the stock. Brooklyn Investment Group raised its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in shares of Clorox in the 3rd quarter worth about $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP boosted its stake in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new position in Clorox during the 3rd quarter valued at about $48,000. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.